Container for colonic cleansing kit

- C.B. Fleet Company, Inc.
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a top perspective view of a container for colonic cleansing kit with the lid closed showing our new design;

FIG. 2 is a bottom perspective view thereof with the lid closed;

FIG. 3 is a top view thereof with the lid closed;

FIG. 4 is a bottom view thereof with the lid closed;

FIG. 5 is a front view thereof with the lid closed;

FIG. 6 is a rear view thereof with the lid closed;

FIG. 7 is a right side view thereof with the lid closed;

FIG. 8 is a left side view thereof with the lid closed; and,

FIG. 9 is a top perspective view thereof with the lid open.

Claims

The ornamental design for a container for colonic cleansing kit, as shown and described.

Referenced Cited
U.S. Patent Documents
3933296 January 20, 1976 Ruskin et al.
D283487 April 22, 1986 Holewinski et al.
D288481 February 24, 1987 Holewinski et al.
D288606 March 3, 1987 Blatherwick et al.
H859 December 4, 1990 Augustine
5013716 May 7, 1991 Cherukuri et al.
5106632 April 21, 1992 Wong et al.
5124144 June 23, 1992 Giorgetti et al.
5274001 December 28, 1993 Borody
5498425 March 12, 1996 Wood et al.
5616346 April 1, 1997 Aronchick
5688529 November 18, 1997 Lidgate et al.
5997906 December 7, 1999 Wood et al.
6103268 August 15, 2000 Borody et al.
6156332 December 5, 2000 Bakal et al.
6162464 December 19, 2000 Jacob et al.
6361799 March 26, 2002 Palkhiwala
D472140 March 25, 2003 Yang
6644472 November 11, 2003 Coppedge et al.
6737068 May 18, 2004 Durden
6806256 October 19, 2004 Ulrich et al.
6866873 March 15, 2005 Stern
6906038 June 14, 2005 Mazer
6946149 September 20, 2005 Cleveland
D515438 February 21, 2006 Baranowski et al.
7101572 September 5, 2006 Santos et al.
7169381 January 30, 2007 Barras et al.
D554493 November 6, 2007 Bochmann et al.
7332184 February 19, 2008 Vanner et al.
D596935 July 28, 2009 Golota et al.
D609085 February 2, 2010 Brachman et al.
D622588 August 31, 2010 Wichmann et al.
7867521 January 11, 2011 Ayala et al.
7985429 July 26, 2011 Caswell
7998510 August 16, 2011 Caswell
8129430 March 6, 2012 Caswell et al.
D663633 July 17, 2012 Rivera et al.
8263136 September 11, 2012 Caswell
20020137803 September 26, 2002 Kirkland
20040071779 April 15, 2004 Keiser et al.
20040101491 May 27, 2004 Stier
20040115282 June 17, 2004 Keiser et al.
20040143005 July 22, 2004 Barras et al.
20040170698 September 2, 2004 Halow
20040192614 September 30, 2004 Vanner et al.
20050061861 March 24, 2005 Pennino
20050271749 December 8, 2005 Borody et al.
20060051428 March 9, 2006 Ayala et al.
20070082061 April 12, 2007 Ayala et al.
20070207216 September 6, 2007 Caswell
20080044489 February 21, 2008 Caswell
20080145445 June 19, 2008 Ayala et al.
20110274765 November 10, 2011 Caswell
20110308988 December 22, 2011 Caswell
Foreign Patent Documents
541665 August 1959 BE
0396165 November 1990 EP
WO 88/03762 June 1988 WO
WO 89/05659 June 1989 WO
WO 93/17589 September 1993 WO
WO 94/12191 June 1994 WO
WO 98/26776 June 1998 WO
WO 98/43654 October 1998 WO
WO 2004/032926 April 2004 WO
WO 2004/037292 May 2004 WO
WO 2008/028632 March 2006 WO
WO 2006/118562 November 2006 WO
WO 2007/022435 February 2007 WO
WO 2007/044681 April 2007 WO
Other references
  • Verghese, V.J. et al., “Low-salt Bowel Cleansing Preparation (LoSo Prep) as Preparation for Colonoscopy: A Pilot Study”, Aliment Pharmacol Ther, vol. 16, pp. 1327-1331, (2002).
  • Reddy, D. et al., “Efficacy and Safety of Oral Sodium Phosphate Versus Polyethylene Glycol Solution for Bowel Preparation for Colonoscopy”, Indian Journal of Gastroenterology, vol. 21, pp. 219-221, (2002).
  • Martinek, J. et al., “Preparation of the Gut Before Colonoscopy”, Prakt., vol. 82, pp. 472-476, (2002). (original and translated version).
  • Web Page: Wild Resolver, Obtained from: www.wild.de/wild/opencms/en/innovation/technology/wild—innovation—technology—resolver.html, p. 1, Printed: Aug. 20, 2004.
  • Web Page: Crystal Light Product Information, Obtained from: www.kraftfoods.com/crystallight/cl—products.html, pp. 1-2, Printed: Feb. 17, 2004.
  • Web Page: Kraft Food Products, Pink Lemonade, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095019&print—show=1&U3=******4300095019***, p. 1, Printed: May 19, 2004.
  • Web Page: Kraft Food Products, Lemonade, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095023&print—show=1&U3=******4300095023***, p. 1, Printed: May 19, 2004.
  • Web Page: Kraft Food Products, Sunrise Classic Orange, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300094541&U3=******4300094541***, p. 1, Printed: May 18, 2004.
  • Web Page: Kraft Food Products,Tangerine Strawberry, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095024&U3=******4300095024***, p. 1, Printed: May 19, 2004.
  • Web Page: Kraft Food Products, Rasberry Ice, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095028&print—show=1&U3=******4300095028***, p. 1, Printed: May 19, 2004.
  • Web Page: Kraft Food Products, Rasberry Peach, Obtained from: www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095026&print—show=1&U3=******4300095026***, p. 1, Printed: May 19, 2004.
  • Anonymous, “Product Information—Crystal Light Iced Tea Decaffeinated Sugar Free”., http://www.kraftfoods.com/main.aspx?s=product&m=product/Product—display&Site=1&Product=4300095016, p. 1, Printed: Dec. 2, 2005.
  • Anonymous, “Product Information—Jell-O Gelatin Dessert Orange 0 carb Sugar Free 10.2g”., hrrp://www.greatlowcarb.com/product.php?p=4085?w=100>.,pp. 1-2, Printed: Dec. 2, 2005
  • International Search Report and Written Opinion dated Jan. 11, 2006 for corresponding PCT application No. PCT/US2005/028132.
  • Web Page: Crystal Light-Lemonade-Pink Lemonade Sugar Free Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095019&print—show=1, 1 page, printed Apr. 30, 2007.
  • Web Page: Crystal Light-Lemonade-Raspberry Lemonade Sugar Free Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300094963&print—show=1, 1 page, printed Apr. 30, 2007.
  • Web Page: Crystal Light-Fruit Drinks-Strawberry-Kiwi Sugar Free Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095008&print—show=1, 1 page, printed Apr. 30, 2007.
  • Web Page: Crystal Light-Fruit Drinks-Strawberry-Orange-Banana Sugar Free Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095009&print—show=1, 1 page, printed Apr. 30, 2007.
  • Web Page: Crystal Light-Fruit Drinks-Pineapple-Orange Sugar Free Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300095022&print—show=1, 1 page, printed Apr. 30, 2007.
  • Web Page: Crystal Light-Sunrise-Sunrise Ruby Red Grapefruit Product Information, Obtained from: http://www.kraftfoods.com/knet—print—version.aspx?s=product&m=product/product—display&Product=4300097199&print—show=1, 1 page, printed Apr. 30, 2007.
  • Anal Itching [online] retrieved on Nov. 5, 2006; retrieved from the Internet [http://www.cnn.com/HEALTH/library/DS/00453.html]; pp. 1-4, May 5, 2006.
  • Met-Rx Berry Drink Data sheet online [retrieved Mar. 21, 2002] http://www.physicallyelite.com/store/store.cfm?do=detail&product—id=12384, pp. 1-5.
  • Ingredient list for EAS Myoplex original nutrition shake.
  • Myoplex datasheet online [retrieved Nov. 10, 2000] http://eas.com/index.asp, Myoplex pp. 1-2.
  • Rao, “Toxicologic Pathology of the Kidney and Urinary Bladder,” Toxicologic Pathology, vol. 30, No. 6, pp. 651-656, 2002.
  • Vanner et al., “A Randomized Prospective Trial Comparing Oral Sodium Phosphate with Standard Polyethylene Glycol-Based Lavage Solution (Golytely) in the Preparation of Patients for Colonoscopy,” The American Journal of Gastroenterology, vol. 85, No. 4, pp. 422-427, 1990.
  • Tobili et al., “Potassium citrate administration ameliorates tubulointerstitial lesions in rats with uric acid nephropathy,” Clinical Nephrology, vol. 55, No. 1, pp. 59-68, 2001.
  • Lacour et al., “Effet du citrate et des phosphate sur le transport du calcium dans l'iléon de rat in vitro,” Gastroenterol Clin. Biol., 18, pp. 938-944, 1994. (Summary in English).
  • Oikawa et al., “Modulation of plasminogen activator inhibitor-1 in vivo : A new mechanism for the anti-fibrotic effect of rennin-angiotensin inhibition,” Kidney International, vol. 51, pp. 164-172, 1997.
  • Marangella et al., “Crystallization Inhibitors in the Pathophysiology and Treatment of Nephrolithiasis,” Urologia Int., 72, Suppl. 1, pp. 6-10, 2004.
  • Neuhofer et al., “Chronic COX-2 inhibition reduces medullary HSP70 expression and induces papillary apoptosis in dehydrated rats,” Kidney International, vol. 65, pp. 431-441, 2004.
  • Ma et al., “Model of robust induction of glomerulosclerosis in mice: Importance of genetic background,” Kidney International, vol. 64, pp. 350-355, 2003.
  • Smoyer et al., “Ischemic Acute Renal Failure Induces Differential Expression of Small Heat Shock Proteins,” J Am Soc Nephrol, 11, pp. 211-221, 2000.
  • Desmeules et al., “Acute Phosphate Nephropathy and Renal Failure,” NEJM, 349, pp. 1006-1007, 2003.
  • Markowitz et al., “Acute Phosphate Nephropathy following Oral Sodium Phosphate Bowel Purgative: An Underrecognized Cause of Chronic Renal Failure,” J Am Soc Nephrol, 16, pp. 3389-3398, 2005.
  • Markowitz et al., “Renal Failure Due to Acute Nephrocalcinosis Following Oral Sodium Phosphate Bowel Cleansing,” Human Pathology, 35, 675-684, 13 pages total, 2004.
  • Ritskes-Hoitinga et al., “Phosphorus-Induced Nephrocalcinosis and Kidney Function in Female Rats,” J. Nutr., 119, pp. 1423-1431, 1989.
  • Orias et al., “Extreme Hyperphosphatemia and Acute Renal Failure after a Phosphorus-Containing Bowel Regimen,” Am J Nephrol, 19, pp. 60-63, (1999).
  • Fine et al., “Severe Hyperphosphatemia Following Phosphate Administration for Bowel Preparation in Patients With Renal Failure: Two Cases and a Review of the Literature,” American Journal of Kidney Diseases, vol. 29, No. 1, pp. 103-105, (1997).
  • Wangoo et al., “Chronobiology of urinary citrate excretion amongst stone-fomers and healthy males from North Western India”, Urological Research, 19:203-206, (1991).
  • Moeckel et al, “Distribution of de novo synthesized betaine in rat kidney: role of renal synthesis on medullary betaine accumulation,” Am. J. Physiol., 272, pp. F94-F99, (1997).
  • Moeckel at al, “COX2 Activity Promotes Organic Osmolyte Accumulation and Adaptation of Renal Medullary Interstitial Cells to Hypertonic Stress,” Journal of Biological Chemistry, vol. 278, No. 21, pp. 19352-19357, (2003).
  • Moeckel et al., “Role of integrin α1β1 in the regulation of renal medullary osmolyte concentration,” Am J Physiol, Renal Physiol, 290, pp. F223-F231, (2006).
  • Marshall et al., “Prospective, randomized trial comparing sodium phosphate solution with polyethylene glycol-electrolyte lavage for colonoscopy preparation,” Gastrointestinal Endoscopy, vol. 39, No. 5, pp. 631-634, (1993).
  • Petsite.com Ltd., “Amazing Rodent Facts,” located at http://www.petalia.com.au/templates/StoryTemplate—Process.cfm?Story—No=350, p. 1, printed Nov. 2007.
  • Nie at al., “Distinct Contributions of T1R2 and T1R3 Taste Receptor Subunits to the Detection of Sweet Stimuli,” Current Biology, vol. 15, pp. 1948-1952, (2005).
  • International Food Information Council Foundation, “Everything You Need to Know About Sucralose,” 2 pages, (1998).
  • International Food Information Council Foundation, “Everything You Need to Know About Acesulfame Potassium,” 2 pages, (1998).
  • Calorie Control Council, “Low-Calorie Sweeteners: Acesulfame Potassium,” can be found at http://www.caloriecontrol.org/acesluf.html, 3 pages, (2004).
  • International Food Information Council Foundation, “Low-Calorie Sweeteners:Adding Reduced-Calorie Delights to a Healthful Diet,” can be found at http://www.ific.org/foodinsight/1998/jf/lcsfi198.cfm?renderforprint=1, 4 pages, (1998).
  • International Food Information Council Foundation, “More Choices For The Sweet Life,” can be found at http://www.ific.org/foodinsight/2002/so/morechoicesfi502.cfm?renderforprint=1, 3 pages, (2002).
  • FoodProductionDaily.com/Europe, “Sweet taste study promises perfect sugar replacement,” can be found at http://www.foodproductiondaily.com/news/printNewsBis.asp?id=63743, 2 pages, (2005).
  • International Search Report dated Mar. 29, 2007 for application no. PCT/US2006/039419.
  • Khashab, M. et al., “Efficacy and tolerability of a new formulation of sodium phosphate tablets (INKP-101), and a reduced sodium phosphate dose, in colon cleansing: a single-center open-label pilot trial”, Aliment Pharmacol Ther., vol. 21, pp. 465-468, (2005).
  • Rex, D.K. et al., “Safety and efficacy of two reduced dosing regimens of sodium phosphate tablets for preparation prior to colonoscopy”, Aliment Pharmacol Ther., vol. 16, pp. 937-944, (2002).
  • Salix Pharmaceuticals, Inc., “Visicol® Product Information”, http://www.salix.com/products—visicol.aspx, 1 page, printed on Aug. 16, 2006.
  • InKine Pharmaceutical Company, Inc., “INKP-102 Tablet Posters; A new purgative from InKine Pharmaceutical Company, Inc., a subsidiary of Salix Pharmaceuticals”, American College of Gastroenterology, Annual Scientific Meeting, 28 pages, Oct. 30-Nov. 2, 2005.
  • Gatorade Sports Science Institute, “Roundtable; Intestinal fluid absorption in exercise and disease”, SSE Roundtable #11, found at http://gssiweb.com/Article—Detail.aspx?articleid=50&level=4&topic=5, vol. 4, No. 1, 5 pages, (1993), (2002).
  • McNaught, A.D. “Nomenclature of carbohydrates; recommendations 1996”, Pure & Applied Chemistry, vol. 68, No. 10, pp. 1919-2008, (1996).
  • Gatorade Beverage Comparison Chart, http://www.gssiweb.com/pdf/gatorade—bev—chart.pdf#search=%22gatorade%20beverage%20comparison%20chart%22, 2 pages, printed Sep. 2005.
  • Sports Drink Comparisons, The University of Arizona, Group 14, Honors Biology 181, Fall 1998, found at http://student.biology.arizona.edu/honors98/group14/sportsdrinks.html, 2 pages, printed on Feb. 25, 2008.
  • Accelerade, “Sports Drink Comparison”, PacificHealth Laboratories, Inc., found at http://www.accelerade.com/pages/product—compare.html, 1 page, printed on Sep. 29, 2005.
  • All-Sport Body Quencher, “Product Comparison”, found at http://www.drinkallsport.com/pop/product—compare.htm, 1 page, printed on Sep. 29, 2005.
  • Afridi, S.A. et al., “Prospective, randomized trial comparing a new sodium phosphate-bisacodyl regimen with conventional PEG-ES lavage for outpatient colonoscopy preparation,” Gastrointestinal Endoscopy, pp. 485-489, vol. 41, (1995).
  • Arezzo, A. “Prospective randomized trial comparing bowel cleaning preparations for colonoscopy,” Surgical Laparoscopy: Endoscopy & Percutaneous Techniques, pp. 215-217, vol. 10, No. 4, (2000).
  • Aronchick, C.A. et al., “A novel tableted purgative for colonoscopic preparation: efficacy and safety comparisons with Colyte and Fleet Phospho-Soda,” Gastrointestinal Endoscopy, pp. 346-352, vol. 52, No. 3, (2000).
  • Avery, M.E. at al., “Oral therapy for acute diarrhea: The underused simple solution,” The New England Journal of Medicine, pp. 891-894, vol. 323, No. 13, (1990).
  • Barclay, R.L. et al., “Carbohydrate-electrolyte rehydration protects against intravascular volume contraction during colonic cleansing with orally administered sodium phosphate”, Gastrointestinal Endoscopy, pp. 633-638, vol. 56, No. 5, (2002).
  • Bawani, M. et at., “A Single Blinded, Prospectively Randomized Comparison of Oral Phosphosoda (OP) with Polyethylene Glycol Based Solution (PG) as a Colonic Lavage for Colonoscopy,” Am. J. Gastroent., p. 1350, vol. 86, Abstract 239, (1991).
  • Bawani, M.H. at al., “A Single Blind Control Study of Fleet Oral Phosphosoda Laxative and Magnesium Citrate for Colonoscopy Preparation,” AJG, p. 1964, vol. 91, Abstract 316, (1996).
  • Berkelhammer, C. et al., “Low-Volume Oral Colonoscopy Bowel Preparation: Sodium Phosphate and Magnesium Citrate,” Gastrointestinal Endoscopy, pp. 89-94, vol. 56, No. 1, (2002).
  • Bujnada, L. et al., “Tolerance and Colon Cleansing with Two Preparations. Polyethylene Glycol Versus Sodium Phosphate,” Gastroenterologia Y. Hepatologia, pp. 9-12, vol. 24, (2001).
  • Chaleoykitti, B., “Comparative Study Between Polyethylene Glycol and Sodium Phosphate Solution in Elective Colorectal Surgery,” J. Med. Assoc. Thai, pp. 92-96, vol. 85, (2002).
  • Chan, A. et al., “Use of Oral Sodium Phosphate Colonic Lavage Solution by Canadian Colonoscopists: Pitfalls and Complications,” Can J. Gastroenterol., pp. 334-338, vol. 11, No. 4, (1997).
  • Chia, Y.W. at al., “Role of Oral Sodium Phosphate and Its Effectiveness in Large Bowel Preparation for Out-Patient Colonoscopy,” J.R. Coll. Surg. Edinb., pp. 374-376, vol. 40, (1995).
  • Chilton, A.P. at al., “A Blinded, Randomized Comparison of a Novel, Low-Dose, Triple Regimen with Fleet Phospho-Soda: A Study of Colon Cleanliness, Speed and Success of Colonoscopy,” Endoscopy, pp. 37-41, vol. 32, No. 1, (2000).
  • Clarkston, W.K. at al., “Oral sodium phosphate versus sulfate-free polyethylene glycol electrolyte lavage solution in outpatient preparation for colonoscopy: a prospective comparison,” Gastrointest. Endosc., pp. 42-48, vol. 43, (1996).
  • Cohen, S.M. et al., “Prospective, randomized, endoscopic-blinded trial comparing precolonoscopy bowel cleansing methods,” Dis. Colon Rectum, pp. 689-696, vol. 37, (1994).
  • Da Silva, M.M. et al., “Colonoscopy preparation in children: safety, efficacy, and tolerance of high- versus low-volume cleansing methods,” Journal of Pediatric Gastroenterology and Nutrition, pp. 33-37, vol. 24, (1997).
  • Del Piano, M. et al., “A comparison of 3 methods of preparation for colonoscopy,” Minerva Gastroenterol. Dietol, pp. 89-92, vol. 39, (1993).
  • Fernandez, J.M.P. et al., “Characterization of the safety, effectiveness and use of oral sodium phosphate,” Revista Espanola De Enferm. Digestivas, pp. 220-225, vol. 93, No. 4, (2001).
  • Frommer, D. “Cleansing ability and tolerance of three bowel preparation for colonoscopy,” Dis. Colon Rectum, pp. 100-104, vol. 40, (1997).
  • Golub, R.W. et al., “Colonoscopic Bowel Preparations—Which One?,” Dis. Colon. Rectum., pp. 594-599, vol. 38, (1995).
  • Greenleaf, J.E. at al., “Plasma volume expansion with oral fluids in hypohydrated men at rest and during exercise,” Aviat Space Environ. Med., pp. 837-844, vol. 69, (1998).
  • Gremse, D.A. et al., “Comparison of oral sodium phosphate to polyethylene glycol-based solution for bowel preparation for colonoscopy in children,” J. Ped. Gast. And Nutrition, pp. 586-590, vol. 23, (1996).
  • Habr-Gama, A., “Bowel preparation for colonoscopy: comparison of mannitol and sodium phosphate: results of a prospective randomized study,” Rev. Hosp. Clin. Fac. Med. S. Paulo, pp. 187-192, vol. 54, No. 6, (1999).
  • Handelsman, J.C. at al., “Experience with ambulatory preoperative bowel preparation at the Johns Hopkins hospital,” Arch. Surg., pp. 441-444, vol. 128, (1993).
  • Haroon, at al., “A randomized clinical trial comparing oral sodium phosphate (NaP) with standard polyethylene glycol-based lavage solution (Colyte) in the preparation of patients for colonoscopy,” Gastroenterology, vol. 102, No. 4, Abstract No. 2112, (1992).
  • Henderson, J.M. et al., “Single-day, divided-dose oral sodium phosphate laxative versus intestinal lavage as preparation for colonoscopy: efficacy and patient tolerance,” Gastrointest. Endoscopy, pp. 238-243, vol. 42, No. 3, (1995).
  • Hookey, L.C. et al., “The safety profile of oral sodium phosphate for colonic cleansing before colonoscopy in adults”, Gastrointest. Endoscopy, vol. 56, No. 6, pp. 895-902, (2002).
  • Huynh, T. et al., “Safety profile of 5-h oral sodium phosphate regimen for colonoscopy cleansing: lack of clinically significant hypocalcemia or hypovolemia,” Am. J. Gastroenterol., pp. 104-107, vol. 90, (1995).
  • Johnson, D.R. et al., “Dehydration and orthostatic vital signs in women with hyperemesis gravidarum” Acad. Emerg. Med., pp. 692-697, (7 pages including correction), vol. 2, (1995).
  • Kim, M. at al., “Patient compliance and satisfaction with oral bowel preparation for outpatient colonoscopy: a prospective, randomized, blinded trial,” Dis. Colon Rectum, vol. 40, pp. A42, Abstract No. P48, (1997).
  • Klein, S. at al., “Enteral and parenteral nutrition,” Sleisenger and Fordtran's Gastrointestinal and Liver Disease, pp. 254-277, (1998).
  • Kolts, B.E. et al., “A comparison of the effectiveness and patient tolerance of oral sodium phosphate, castor oil, and standard electrolyte lavage for colonoscopy or sigmoidoscopy preparation,” Am. J. Gastroenterol., pp. 1218-1223, vol. 88, No. 8, (1993).
  • Kuchel, G.A. et al., “Cardiovascular responses to phlebotomy and sitting in middle-aged and elderly subjects,” Arch. Int. Med., pp. 366-370, vol. 152, (1992).
  • Lapalus, M-G. et al., “Prospective randomized single-blind trial comparing oral sodium phosphate and polyethylene glycol based solution for colonoscopy preparation,” Gastroenterol. Clin. Biol., pp. 29-34, vol. 25, (2001).
  • Lee, J. et al., “A prospective randomised study comparing polyethylene glycol and sodium phosphate bowel cleansing solutions for colonoscopy,” The Ulster Medical Journal, pp. 68-72, vol. 68, No. 2, (1999).
  • McGee, S.R., “Physical examination of venous pressure: a critical review,” Am. Heart J., pp. 10-18, vol. 136, (1998).
  • Macari, M. et al., “Effect of different bowel preparations on residual fluid at CT colonography,” Radiology, pp. 274-277, vol. 218, (2001).
  • Macleod, A.J.M. et al., “A comparison of fleet phospho-soda with picolax in the preparation of the colon for double contrast barium enema,” Clinical Radiology, pp. 612-614, vol. 53, (1998).
  • Marshall, J.B. at al., “Short report: prospective, randomized trial comparing a single dose sodium phosphate regimen with PEG-electrolyte lavage for colonoscopy preparation,” Aliment Pharmacol. Ther., pp. 679-682, vol. 7, (1993).
  • Marshall, J.B. et al., “Prospective, randomized trial comparing sodium phosphate solution with polyethylene glycol-electrolyte lavage for colonoscopy preparation,” Gastrointest. Endosc., pp. 631-634, vol. 39, No. 5, (1993).
  • Martinek, J. et al., “Cisapride does not improve precolonoscopy bowel preparation with either sodium phosphate or polyethylene glycol electrolyte lavage,” Gastrointest. Endoscopy, pp. 180-185, vol. 54, No. 2, (2001).
  • Maughan, R.J. et al., “Post-exercise rehydration in man: effects of electrolyte addition to ingested fluids,” Eur. J. Appl. Physiol. Occup. Physiol., pp. 209-215, vol. 69, (1994).
  • O'Donovan, A.N. et al., “A prospective blinded randomized trial comparing oral sodium phosphate and polyethylene glycol solutions for bowel preparation prior to barium enema,” Clin. Radiology, pp. 791-793, vol. 52, (1997).
  • Oliveria, L.C.C. et al., “Mechanical bowel preparation for elective colorectal surgery; a prospective, randomized, surgeon-blinded trial comparing sodium phosphate and polyethylene glycol-based oral lavage solutions,” Dis. Colon Rectum, pp. 585-591, vol. 40, (1997).
  • Poon, C.M. at al., “Two liters of polyethylene glycol-electrolyte lavage solution versus sodium phosphate as bowel cleansing regimen for colonoscopy: a prospective randomized controlled trial,” Endoscopy, pp. 560-563, vol. 34, (2002).
  • Rex, D.K. et al., “Impact of bowel preparation on efficacy and cost of colonoscopy,” Am. J. Gastroenterology, pp. 1696-1700, vol. 97, No. 7, (2002).
  • Shaoul, R. et al., “Symptoms of hyperphosphatemia, hypocalcemia, and hypomagnesemia in an adolescent after the oral administration of sodium phosphate in preparation for a colonoscopy,” Gastrointest. Endosc., pp. 650-652, vol. 53, No. 6, (2001).
  • Sudduth, R.H. et al., “The effectiveness of simethicone in improving visibility during colonoscopy when given with a sodium phosphate solution: a double-blind randomized study,” Gastrointest. Endoscopy, pp. 413-415, vol. 42, No. 5, (1995).
  • Thomson, A. et al., “Bowel preparation for colonoscopy: a randomized prospective trial comparing sodium phosphate and polyethylene glycol in a predominantly elderly population,” J. Gast. and Hepatology, pp. 103-107, vol. 11, (1996).
  • Unal, S. et al., “A randomized prospective trial comparing 45 and 90-ml oral sodium phosphate with X-Prep in the preparation of patients for colonoscopy,” Acta. Gastro-Enterol. Belg., pp. 281-284, vol. 61, (1998).
  • Wolff, B.G. at al., “A new bowel preparation for elective colon and rectal surgery: a prospective, randomized clinical trial,” Arch. Surg., pp. 895-900, vol. 123, (1998).
  • Yoshioka, K. et al., “Randomized trial of oral sodium phosphate (picolax) for elective colorectal surgery and colonoscopy,” Dig. Surg., pp. 66-70, vol. 17, (2000).
  • Young, C.J. et al., “Oral sodium phosphate solution is a superior colonoscopy preparation to polyethylene glycol with bisacodyl,” Dis. Colon Rectum, pp. 1568-1571, vol. 43, (2000).
  • Tjandra, J. at al., “Carbohydrate-Electrolyte (E-Lyte®) Solution Enhances Bowel Preparation With Oral Fleet® Phospho-soda®”, Dis Colon Rectum, 47, pp. 1181-1186, (2004).
  • Canard, J. at al., “Fleet® Phospho Soda: for Greater Acceptability of the Colic Preparation Before Colonoscopy. Randomized Comparative Single Blind Study Versus Polyethylene Glycol.” Acta. Endoscopica, pp. 703-708, vol. 31, (2001).
  • Translation of the Canard, J., et al reference.
  • Oliveira, L. et al., “Mechanical Bowel Preparation With Oral Sodium Phosphate Solution for Colonoscopy. A New Small Volume Solution Compared To The Traditional Mannitol.”, Revista do Colegio Brasileiro de Cirurgioes, pp. 353-358, vol. 26, (1999).
  • Translation of the Oliveira, L. et al reference.
  • Salix Pharmaceuticals, Inc., Visicol® Tablets Product Information, 2 pages, (2005).
  • Isbrucker, R.A. et al., “Risk and safety assessment on the consumption of licorice root (Glycyrrhiza sp.), its extract and powder as a food ingredient, with emphasis on the pharmacology and toxicology of glycyrrhizin”, Regulatory Toxicology and Pharmacology, vol. 46, pp. 167-192, (2006).
  • Translation of the Belgium Patent BE 541665 dated Aug. 1959.
  • Unger et al., “Willingness to Undergo Split-Dose Bowel Preparation for Colonoscopy and Compliance with Split-Dose Instructions,” Dig Dis Sci, pp. 2030-2034, (2010).
  • Balaban, D.H. et al., “Comparison of two dosing regimens of liquid sodium phosphate against a low dose PEG regimen”, American Journal of Gastroenterology, vol. 100, No. 9 supplement, pp. S354-S355, (2005).
  • Food and Drug Administration, “Guidance for Industry: Container closure systems for packaging human drugs and biologics”, U.S. Department of Health and Human Services, pp. 1-56, (1999).
  • Rex, D.K. et al., “Updated recommendations on the safe and effective use of oral sodium phosphates solution” Fleet, found at www.fleetlabs.com/notices/UpdatedRecommendationsOSPS.pdf, pp. 1-10, printed on Jan. 13, 2012, (2007).
  • DiPalma, J.A. et al., “Biochemical effects of oral sodium phosphate”, Digestive Diseases and Sciences, vol. 41, No. 4, pp. 749-753, (1996).
  • Ainley, E.J. et al., “Measurement of serum electrolytes and phosphate after sodium phosphate colonoscopy bowel preparation: an evaluation”, Digestive Diseases and Sciences, vol. 50, No. 7, pp. 1319-1323, (2005).
  • Malik, P. et al., “Randomized study comparing two refimens of oral sodium phosphates solution versus low-dose polyethylene glycol and bisacodyl”, Digestive Diseases and Sciences, vol. 54, No. 4, pp. 833-841, published online Aug. 19, 2008, (2009).
  • International Search Report dated Dec. 4, 2008 for PCT Application No. PCT/US08/073855.
  • Gimenez, L., et al., “Prevention of phosphate-induced progression of uremia in rats by 3-phosphocitric acid”, Kidney International, vol. 22, pp. 36-41, (1982).
  • Zechner, V. O., et al., “The Conservative treatment of phosphate calculi with citrate buffer”, Wiener Klinische Wochenschrift, vol. 87, No. 9, pp. 300-303, (1975).
  • Abuelo, J.G. “Normotensive ischemic acute renal failure”, New England Journal of Medicine, vol. 357, pp. 797-805, (2007).
Patent History
Patent number: D683210
Type: Grant
Filed: Aug 10, 2012
Date of Patent: May 28, 2013
Assignee: C.B. Fleet Company, Inc. (Lynchburg, VA)
Inventors: Charles H. Cox (Concord, VA), Michael L. Caswell (Dover, NJ)
Primary Examiner: Thomas Johannes
Application Number: 29/429,438
Classifications
Current U.S. Class: D9/420; D9/424